Published :
Tables : 56
Figures : 48
Category : Healthcare
No. of Pages : 236
Report Code : HC-U3303
High Throughput Screening Market is expected to value over USD 25 billion by 2028 end with a CAGR of over 8% during the forecast period 2022-2028. High-throughput screening (HTS) is a method of discovering new drugs by automated testing of large quantities of chemical and biological compounds against a specific biological target. In the pharmaceutical industry, high-throughput screening methods leverage robotics and automation to rapidly test the biological or biochemical activity of a large number of molecules, usually drugs. In addition to accelerating target analysis, large-scale compound libraries can be cost-effectively screened. In addition to assessing pharmacological targets, HTS is useful for pharmacologically profiling agonists and antagonists for receptors and enzymes (such as GPCRs). Recent advancements in robotics, liquid handling, plate reader detection and high-speed computers have greatly contributed to the modernization of HTS. High-throughput screening help cut drug development costs. Furthermore, this technique allows for the screening of a large number of compounds utilising high-throughput screening (HTS) up to 10,000 compounds each day, and even 100,000 tests using ultrahigh-throughput screening (UHTS). Robots, detectors, and software are used to control the entire process in this method. It's also used to screen a variety of libraries, including combinatorial chemistry, peptide, genomics, and protein libraries. It's also utilised to characterise novel drug metabolic, pharmacokinetic, and toxicological data. The primary goal of implementing any high-throughput screening technique is to speed up the drug discovery process. High-throughput screening techniques have been widely used in the pharmaceutical and biopharmaceutical industries, and they are useful in integrating automation and robotics equipment to evaluate a large number of samples quickly. This high-throughput screening method allows researchers to swiftly identify active chemicals, antibodies, or genes that influence a certain biomolecular pathway. The findings of these tests can be used to help with medication development and studying the noninteraction or role of a certain region. The global high throughput screening market is expected to rise significantly throughout the forecast period, owing to factors such as growing use of high-throughput screening for drug development, which minimises the time it takes to develop a medicine. Furthermore, the discovery of novel treatments for a variety of life-threatening disorders helps to the high-throughput screening market's growth. FutureWise Market Research has instantiated a report that provides an intricate analysis of High Throughput Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the High Throughput Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the High Throughput Screening Market: • Thermo Fisher Scientific • Agilent Technologies Inc • Danaher • PerkinElmer Inc • Tecan Group Ltd • Axxam S.p.A • Bio-Rad Laboratories Inc • Merck Group KGaA • Hamilton Company • Corning Incorporated • Biotek Instruments Inc • Aurora Biomed Inc (Note: The list of the major players will be updated with the latest market scenario and trends) High Throughput Screening Market Segmentation: By Products and Services • Products o Reagents and Assay Kits o Instruments o Software • Services By Technology • Cell-Based Assays o Cell Proliferation Assays o Cell Viability Assays o Cell Cytotoxicity Assays o Cell Death Assays o Other Cell-Based Assays • Lab-on-a-Chips o PDMS o Thermopolymers o Glass o Silicon o Paper • Ultra high throughput Screening o Chip-based Screening o Micro-channel Flow Systems o- Plateless Systems o Others • Label-Free Technology o SPR o ITC o Others By Application • Drug Discovery o Medicinal Chemistry o Biology Services o Drug Metabolism and Pharmacokinetics (DMPK) • Chemical Biology Programs o Cellular & Biological Simulation o Disease Modelling o Preclinical Drug Development o Clinical Trials • Cell & Organ-Based Screening o Drug Discovery o Academic Research • Biochemical Screening o Blood and Blood –based Products o Vaccines and Therapeutics o Stem Cells • Biological Active Compound Screening o Target Identification o Primary Screening o Toxicology • Genomics o Diagnostic Application o Precision Medicine • Proteomics o Drug Diagnostics o Precision Medicine • Compound Profiling o Drug Discovery o Cancer/Tumor Profiling o- Toxicology By Detection Method • Mass Spectrometry o Surface-based MALDI-MS o LASI-MS Imaging o Injection-based MS o Others • Chromatography o HIC o HPLC o SEC o HPGC o Others • Calorimetry o Rapid Mass Calorimeter o ITC o Nanocalorimetry o Array Calorimetry o Others • X-ray Diffraction o In situ Crystallization o In meso Crystallization o Crystal X-ray Diffraction o Others By End-User • Pharmaceutical and Biotechnology Companies • Academic and Government Institutes • Contract Research Organizations (CRO) • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa High Throughput Screening Market Sample Video: FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global high throughput screening market by products and services, by technology, by application, by detection method, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
High-throughput screening (HTS) is a method of discovering new drugs by automated testing of large quantities of chemical and biological compounds against a specific biological target. In the pharmaceutical industry, high-throughput screening methods leverage robotics and automation to rapidly test the biological or biochemical activity of a large number of molecules, usually drugs. In addition to accelerating target analysis, large-scale compound libraries can be cost-effectively screened. In addition to assessing pharmacological targets, HTS is useful for pharmacologically profiling agonists and antagonists for receptors and enzymes (such as GPCRs). Recent advancements in robotics, liquid handling, plate reader detection and high-speed computers have greatly contributed to the modernization of HTS.
High-throughput screening help cut drug development costs. Furthermore, this technique allows for the screening of a large number of compounds utilising high-throughput screening (HTS) up to 10,000 compounds each day, and even 100,000 tests using ultrahigh-throughput screening (UHTS). Robots, detectors, and software are used to control the entire process in this method. It's also used to screen a variety of libraries, including combinatorial chemistry, peptide, genomics, and protein libraries. It's also utilised to characterise novel drug metabolic, pharmacokinetic, and toxicological data. The primary goal of implementing any high-throughput screening technique is to speed up the drug discovery process. High-throughput screening techniques have been widely used in the pharmaceutical and biopharmaceutical industries, and they are useful in integrating automation and robotics equipment to evaluate a large number of samples quickly. This high-throughput screening method allows researchers to swiftly identify active chemicals, antibodies, or genes that influence a certain biomolecular pathway. The findings of these tests can be used to help with medication development and studying the noninteraction or role of a certain region. The global high throughput screening market is expected to rise significantly throughout the forecast period, owing to factors such as growing use of high-throughput screening for drug development, which minimises the time it takes to develop a medicine. Furthermore, the discovery of novel treatments for a variety of life-threatening disorders helps to the high-throughput screening market's growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of High Throughput Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the High Throughput Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the High Throughput Screening Market: • Thermo Fisher Scientific • Agilent Technologies Inc • Danaher • PerkinElmer Inc • Tecan Group Ltd • Axxam S.p.A • Bio-Rad Laboratories Inc • Merck Group KGaA • Hamilton Company • Corning Incorporated • Biotek Instruments Inc • Aurora Biomed Inc (Note: The list of the major players will be updated with the latest market scenario and trends)
High Throughput Screening Market Segmentation: By Products and Services • Products o Reagents and Assay Kits o Instruments o Software • Services By Technology • Cell-Based Assays o Cell Proliferation Assays o Cell Viability Assays o Cell Cytotoxicity Assays o Cell Death Assays o Other Cell-Based Assays • Lab-on-a-Chips o PDMS o Thermopolymers o Glass o Silicon o Paper • Ultra high throughput Screening o Chip-based Screening o Micro-channel Flow Systems o- Plateless Systems o Others • Label-Free Technology o SPR o ITC o Others By Application • Drug Discovery o Medicinal Chemistry o Biology Services o Drug Metabolism and Pharmacokinetics (DMPK) • Chemical Biology Programs o Cellular & Biological Simulation o Disease Modelling o Preclinical Drug Development o Clinical Trials • Cell & Organ-Based Screening o Drug Discovery o Academic Research • Biochemical Screening o Blood and Blood –based Products o Vaccines and Therapeutics o Stem Cells • Biological Active Compound Screening o Target Identification o Primary Screening o Toxicology • Genomics o Diagnostic Application o Precision Medicine • Proteomics o Drug Diagnostics o Precision Medicine • Compound Profiling o Drug Discovery o Cancer/Tumor Profiling o- Toxicology By Detection Method • Mass Spectrometry o Surface-based MALDI-MS o LASI-MS Imaging o Injection-based MS o Others • Chromatography o HIC o HPLC o SEC o HPGC o Others • Calorimetry o Rapid Mass Calorimeter o ITC o Nanocalorimetry o Array Calorimetry o Others • X-ray Diffraction o In situ Crystallization o In meso Crystallization o Crystal X-ray Diffraction o Others By End-User • Pharmaceutical and Biotechnology Companies • Academic and Government Institutes • Contract Research Organizations (CRO) • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
High Throughput Screening Market Sample Video:
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global high throughput screening market by products and services, by technology, by application, by detection method, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. High Throughput Screening Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of High Throughput Screening Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. High Throughput Screening Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. High Throughput Screening Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Reagents and Assay Kits 7.1.2. Instruments 7.1.3. Software 7.2. Services 8. High Throughput Screening Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Drug Discovery 8.1.1. Medicinal Chemistry 8.1.2. Biology Services 8.1.3. Drug Metabolism and Pharmacokinetics (DMPK) 8.2. Chemical Biology Programs 8.2.1. Cellular & Biological Simulation 8.2.2. Disease Modelling 8.2.3. Preclinical Drug Development 8.2.4. Clinical Trials 8.3. Cell & Organ-Based Screening 8.3.1. Drug Discovery 8.3.2. Academic Research 8.4. Biochemical Screening 8.4.1. Blood and Blood –based Products 8.4.2. Vaccines and Therapeutics 8.4.3. Stem Cells 8.5. Biological Active Compound Screening 8.5.1. Target Identification 8.5.2. Primary Screening 8.5.3. Toxicology 8.6. Genomics 8.6.1. Diagnostic Application 8.6.2. Precision Medicine 8.7. Proteomics 8.7.1. Drug Diagnostics 8.7.2. Precision Medicine 8.8. Compound Profiling 8.8.1. Drug Discovery 8.8.2. Cancer/Tumor Profiling 8.8.3. Toxicology 9. High Throughput Screening Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cell-Based Assays 9.1.1. Cell Proliferation Assays 9.1.2. Cell Viability Assays 9.1.3. Cell Cytotoxicity Assays 9.1.4. Cell Death Assays 9.1.5. Other Cell Based Assays 9.2. Lab-on-a-Chip 9.2.1. PDMS 9.2.2. Thermopolymers 9.2.3. Glass 9.2.4. Silicon 9.2.5. Paper 9.3. Ultra High Throughput Screening 9.3.1. Chip-based Screening 9.3.2. Micro-channel Flow Systems 9.3.3. Platess Systems 9.3.4. Others 9.4. Label Free Technology 9.4.1. SPR 9.4.2. ITC 9.4.3. Others 10. High Throughput Screening Market, By Detection Method Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Mass Spectroscopy 10.1.1. Surface-based MALDI-MS 10.1.2. LASI-MS Imaging 10.1.3. Injection-based MS 10.1.4. Others 10.2. Chromatography 10.2.1. HIC 10.2.2. HPLC 10.2.3. SEC 10.2.4. HPGC 10.2.5. Others 10.3. Calorimetry 10.3.1. Rapid Mass Calorimeter 10.3.2. ITC 10.3.3. Nanocalorimetry 10.3.4. Array Calorimetry 10.3.5. Others 10.4. X-Ray Diffraction 10.4.1. in situ Crystallization 10.4.2. in meso Crystallization 10.4.3. Crystal X-ray Diffraction 10.4.4. Others 10.5. Others 11. High Throughput Screening Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others 12. North America High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028 13. Latin America High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028 14. Europe High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028 15. Asia Pacific High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Agilent Technologies Inc. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. PerkinElmer Inc. 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Tecan Group Ltd. 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Axxam S.p.A. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Bio-Rad Laboratories Inc. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Merck Group KGaA 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Hamilton Company 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Corning Incorporated 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Biotek Instruments Inc. 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Aurora Biomed Inc. 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. High Throughput Screening Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of High Throughput Screening Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. High Throughput Screening Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. High Throughput Screening Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Reagents and Assay Kits 7.1.2. Instruments 7.1.3. Software 7.2. Services
8. High Throughput Screening Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Drug Discovery 8.1.1. Medicinal Chemistry 8.1.2. Biology Services 8.1.3. Drug Metabolism and Pharmacokinetics (DMPK) 8.2. Chemical Biology Programs 8.2.1. Cellular & Biological Simulation 8.2.2. Disease Modelling 8.2.3. Preclinical Drug Development 8.2.4. Clinical Trials 8.3. Cell & Organ-Based Screening 8.3.1. Drug Discovery 8.3.2. Academic Research 8.4. Biochemical Screening 8.4.1. Blood and Blood –based Products 8.4.2. Vaccines and Therapeutics 8.4.3. Stem Cells 8.5. Biological Active Compound Screening 8.5.1. Target Identification 8.5.2. Primary Screening 8.5.3. Toxicology 8.6. Genomics 8.6.1. Diagnostic Application 8.6.2. Precision Medicine 8.7. Proteomics 8.7.1. Drug Diagnostics 8.7.2. Precision Medicine 8.8. Compound Profiling 8.8.1. Drug Discovery 8.8.2. Cancer/Tumor Profiling 8.8.3. Toxicology
9. High Throughput Screening Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Cell-Based Assays 9.1.1. Cell Proliferation Assays 9.1.2. Cell Viability Assays 9.1.3. Cell Cytotoxicity Assays 9.1.4. Cell Death Assays 9.1.5. Other Cell Based Assays 9.2. Lab-on-a-Chip 9.2.1. PDMS 9.2.2. Thermopolymers 9.2.3. Glass 9.2.4. Silicon 9.2.5. Paper 9.3. Ultra High Throughput Screening 9.3.1. Chip-based Screening 9.3.2. Micro-channel Flow Systems 9.3.3. Platess Systems 9.3.4. Others 9.4. Label Free Technology 9.4.1. SPR 9.4.2. ITC 9.4.3. Others
10. High Throughput Screening Market, By Detection Method Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Mass Spectroscopy 10.1.1. Surface-based MALDI-MS 10.1.2. LASI-MS Imaging 10.1.3. Injection-based MS 10.1.4. Others 10.2. Chromatography 10.2.1. HIC 10.2.2. HPLC 10.2.3. SEC 10.2.4. HPGC 10.2.5. Others 10.3. Calorimetry 10.3.1. Rapid Mass Calorimeter 10.3.2. ITC 10.3.3. Nanocalorimetry 10.3.4. Array Calorimetry 10.3.5. Others 10.4. X-Ray Diffraction 10.4.1. in situ Crystallization 10.4.2. in meso Crystallization 10.4.3. Crystal X-ray Diffraction 10.4.4. Others 10.5. Others
11. High Throughput Screening Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Online Stores 11.2. Retail 11.3. Others
12. North America High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2022-2028
15. Asia Pacific High Throughput Screening Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. GCC 16.2.2. Israel 16.2.3. South Africa 16.2.4. Rest of MEA 16.3. Market Size (USD Million) Forecast for MEA 2022-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. Agilent Technologies Inc. 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Danaher 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. PerkinElmer Inc. 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Tecan Group Ltd. 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Axxam S.p.A. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Bio-Rad Laboratories Inc. 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. Merck Group KGaA 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Hamilton Company 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.Corning Incorporated 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11.Biotek Instruments Inc. 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12.Aurora Biomed Inc. 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview
19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics